Cybin develops and distributes fungi derived medical products to treat psychedelic, pharmaceutical and nutraceutical disorders.
Business Model:
Revenue: $685k
Employees: 51-200
Address: 100 King St West
City: Toronto
State: ontario
Zip: M5X 1C9
Country: CA
Cybin develops and distributes fungi derived medical products to treat psychedelic, pharmaceutical and nutraceutical disorders.
Contact Phone:
Contact Email:
Listed Exchange:
OTCMKTS
IPO Date:
3/3/2021
Ticker Symbol:
CLXPF
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
12/2020 | Adelia Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|